NCT06866912Recruiting
Observational Epidemiological Study of Patients Suffering From Systemic Amyloidosis
Source: ClinicalTrials.gov · Last updated 10 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
observational epidemiological study of patients affected by systemic amyloidosis
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 750 (estimated)
- First submitted
- 29 Jan 2025
- Start date
- 1 Sept 2023
- Primary completion date
- 31 Aug 2033
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Diseases
- Amyloidosis
- NCT number
- NCT06866912
What you commit to
- Study type: Observational
- Planned participants: 750
- From 1 Sept 2023 to the primary completion date, 31 Aug 2033
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- nothing
Who the study is looking for
- patients diagnosed with amyloidosis or asymptomatic carriers of mutations in the transthyretin gene
- minimum age of 18 years at the time of diagnosis
- obtaining informed consent
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna Coordinator of this site? Confirm its status | Bologna | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.